In situ protein expression of RRM1, ERCC1 and BRCA1 in metastatic breast cancer patients treated with gemcitabine-based chemotherapy

Схожие документы

• Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non–Small-Cell Lung Cancer
  по: Reynolds, Craig, et al.
  Опубликовано: (2009)
• ERCC1 and RRM1 in the International Adjuvant Lung Trial by Automated Quantitative in Situ Analysis
  по: Bepler, Gerold, et al.
  Опубликовано: (2011)
• The Expression of ERCC1, RRM1, and BRCA1 in Breast Cancer According to the Immunohistochemical Phenotypes
  по: Kim, Dokyung, et al.
  Опубликовано: (2011)
• Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma
  по: Akita, H, et al.
  Опубликовано: (2009)
• Randomized International Phase III Trial of ERCC1 and RRM1 Expression–Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non–Small-Cell Lung Cancer
  по: Bepler, Gerold, et al.
  Опубликовано: (2013)